|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-25
|
pharmaceutical
|
|
|
Research and development
|
2013-02-25
|
pyridine-3-carboximidamidehydrochloride
|
|
|
Research and development
|
2013-02-22
|
PALLADIUM HYDROXIDE
|
|
|
Research and development
|
2013-02-21
|
PALLADIUM HYDROXIDE
|
|
|
pharmaceutical
|
2013-02-20
|
pharmaceutical
|
|
|
pharmaceutical
|
2013-02-20
|
pharmaceutical
|
|
|
Pimaricin
CAS No: 7681-93-8
Molecular Formula: C33H47NO13
Formula Wei...
|
2013-02-20
|
Pimaricin
|
|
|
Research and development
|
2013-02-18
|
Pinacol vinylboronate
|
|
|
Research and development
|
2013-02-18
|
Pinacolone
|
|
|
Because of their amphiphilic structure, the polymers have surfactant prope...
|
2013-02-16
|
C5H10O2
|
|
|
Restores vital energy, benefits the lung
|
2013-02-16
|
7-8% HPLCUsage
|
|
|
It is an antibiotic designed to fight intestinal infections such as cryptos...
|
2013-02-16
|
C23H47N5O18S
|
|
|
An angiotensin-converting enzyme (ACE) inhibitor. Antihypertensive
|
2013-02-16
|
C19H32N2O5
|
|
|
The phenformin biguanide oral hypoglycemic agents, this product does not ir...
|
2013-02-16
|
C4H11N5.HCl
|
|
|
The phenformin biguanide oral hypoglycemic agents, this product does not i...
|
2013-02-16
|
C4H11N5.HCl
|
|
|
Improving blood flow in the ischemic tissue nutrition.
|
2013-02-16
|
C17H25NO4HCl
|
|
|
Improving blood flow in the ischemic tissue nutrition.
|
2013-02-16
|
35543-24-9
|
|
|
Piracetam is a nootopric (brain enhancer / smart drug) that is a derivative...
|
2013-02-16
|
4-[(3-Pyridinylcarbonyl)amino]-butanoic acid monosodium salt
|
|
|
Piracetam is a nootopric (brain enhancer / smart drug) that is a derivative...
|
2013-02-16
|
4-[(3-Pyridinylcarbonyl)amino]-butanoic acid monosodium salt
|
|
|
Pharmaceutical raw materials and intermediates
|
2013-02-16
|
C6H10N2O2
|
|
|
Piroxicam is used to relieve the symptoms of rheumatoid and osteoarthritis,...
|
2013-02-16
|
C15H13N3O4S
|
|
|
Piroxicam is used to relieve the symptoms of rheumatoid and osteoarthritis,...
|
2013-02-16
|
C15H13N3O4S
|
|
|
It is for the prevention of vascular headache including migraine and cluste...
|
2013-02-16
|
C19H21NS
|
|
|
organic synthesis intermediate
|
2013-02-16
|
C6H5NaO4S
|
|
|
It is used against Schistosoma.[1] As of 2005, praziquantel is the primary ...
|
2013-02-16
|
C19H24N2O2
|
|
|
treatment of mild to moderate acute bacterial infection
|
2013-02-16
|
C21H20FN3O6S
|
|
|
helmex;
lombriareu;
pirantel pamoate;
pyrantel embonate;
pyrantel p...
|
2013-02-16
|
Pyrantel Pamoate;
|
|
|
PROMESTRIENE (steriods)
Molecular Formula: C22H32O2
Formula Weight: 32...
|
2013-02-07
|
PROMESTRIENE (steriods)
|
|
|
p-acrylic cinnamic acid
Molecular Formula: C12H10O4 cas:6323-43-6
Formula...
|
2013-02-07
|
p-acrylic cinnamic acid
|
|
|
p-Hydroxycinnamaldehyde trans-4-Hydroxycinnamaldehyde appearance:light yell...
|
2013-02-07
|
p-Hydroxycinnamaldehyde trans-4-Hydroxycinnamaldehyde appearance:light yellow crystalline powder assay£º92%£»98% water£º1% CAS: 107-02-8 acid value£º3.0%
|
|
|
P-Methoxybenzaldehyde
CAS: 204-602-6.
Appearance: colorless transparent o...
|
2013-02-07
|
P-Methoxybenzaldehyde
|
|
|
p-methyl cinnamic acid
Molecular Formula: C10H10O2
Formula Weight: 162....
|
2013-02-07
|
p-methyl cinnamic acid
|
|
|
PROMESTRIENE
Molecular Formula: C22H32O2
Formula Weight: 328.49
CAS:39...
|
2013-02-07
|
PROMESTRIENE
|
|
|